HC restrains Patanjali from airing ads criticising Dabur Chyawanprash

The Delhi High Court restrained Patanjali Ayurved from airing TV ads disparaging Dabur's Chyawanprash products, following Dabur's plea for an injunction against the allegedly defamatory campaign.

delhi, high court, delhi high court, delhi HC, HC,
Dabur moved two interim injunction applications in the suit in which summons were issued in December last year.
Bhavini MishraAkshara Srivastava New Delhi
2 min read Last Updated : Jul 03 2025 | 10:43 PM IST
The Delhi High Court on Thursday restrained Patanjali Ayurved from running advertisements that appear to criticise Chyawanprash made by consumer goods company Dabur India, which claimed that the Ramdev-led firm ran thousands of disparaging advertisements against its product.
 
The court’s interim decision came on a plea moved by Dabur India, seeking an injunction against the alleged defamatory advertising campaign.
 
After passing the restraining order, Justice Mini Pushkarna fixed July 14 as the next date of hearing.
 
Dabur had moved two interim injunction applications in December last year, in which summons were issued.
 
In the second injunction application, Dabur alleged that after the issuance of the summons, Patanjali ran thousands of advertisements against its product in one week.  ALSO READ: Diversify manufacturing, supply chains after China's Foxconn exit: CII Prez
 
Patanjali Ayurved has claimed that its product contains 51 herbs, compared to Dabur’s 40, and allegedly suggested that Chyawanprash sold by other brands contains mercury.
 
Dabur has denied such claims, alleging that Patanjali’s advertisement specifically refers to Dabur’s product made with 40 herbs as ‘ordinary’.
 
Dabur has claimed that in the TV and print advertisements, Patanjali has made “fallacious and deliberate misstatements” and serious comparisons, denigrating and defaming the Dabur Chyawanprash.
 
Ramdev was recently pulled up and made to apologise by the Supreme Court for running a campaign against modern medicine in a case filed by the Indian Medical Association.
 
He also gave an undertaking in the Delhi High Court in May this year, saying that he will not issue any disparaging statement against Hamdard’s Rooh Afza.
 
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :PatanjaliPatanjali AyurvedaDaburDelhi High Court

First Published: Jul 03 2025 | 5:05 PM IST

Next Story